US Broker Ratings

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 54% Potential Upside in the Pediatric Orthopedic Market

OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector as a leader in pediatric orthopedic medical devices. With a market capitalization of $427.76 million, this..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: A 236% Potential Upside Beckons Bold Investors

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is an intriguing player in the biotechnology sector, attracting investors with its significant potential upside of 236.05%. Headquartered in San Diego,..

Phibro Animal Health Corporation (PAHC): Valuation Insights and Growth Potential Amid Revenue Surge

Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, is garnering attention with its robust revenue growth of 38.60% over the past..

Xeris Biopharma Holdings (XERS) Stock Analysis: Navigating High Growth in the Biotechnology Sector

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) has been making waves in the biotechnology sector with its innovative approach to treating chronic endocrine and neurological diseases. With..

Community Health Systems, Inc. (CYH) Stock Report: Analyzing the 9.33% Potential Upside

Community Health Systems, Inc. (NYSE: CYH) stands as a significant player in the U.S. healthcare sector, specifically within the medical care facilities industry. Headquartered in Franklin,..

GH Research PLC (GHRS) Stock Analysis: Unpacking the 134% Potential Upside for Biotech Investors

GH Research PLC (NASDAQ: GHRS) is capturing the attention of investors in the biotechnology space with its compelling potential upside of 134.32%. As a clinical-stage biopharmaceutical..

STAAR Surgical Company (STAA) Stock Analysis: Navigating the High-Risk, High-Reward Landscape in Medical Devices

STAAR Surgical Company (NASDAQ: STAA) operates within the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in Lake Forest, California, STAAR Surgical specializes..

CorMedix Inc. (CRMD): Unpacking the 71.78% Potential Upside in this Biotech Stock

CorMedix Inc. (NASDAQ: CRMD) is capturing investor attention with a striking potential upside of 71.78%, as suggested by its average target price of $19.43. This figure..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Exploring a 93% Upside Potential in Biotech

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a promising player in the biotechnology sector, is capturing investor attention with its robust potential upside of 93.43%. This clinical-stage biopharmaceutical..

Sionna Therapeutics, Inc. (SION) Stock Analysis: What Investors Need to Know About Its 52-Week Highs and Pipeline Potential

Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its focus on developing innovative treatments for cystic..

Nuvation Bio Inc. (NUVB) Stock Analysis: Unveiling an 86% Potential Upside in the Biotech Arena

Nuvation Bio Inc. (NYSE: NUVB) has emerged as a compelling player in the biotechnology sector, drawing significant attention from investors due to its substantial growth potential...

Spyre Therapeutics (SYRE) Investor Outlook: Unpacking a Potential 136% Upside

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is capturing the attention of investors with its promising developments in the biotechnology sector, specifically targeting inflammatory bowel disease (IBD). With..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: A Biotech Gem with Nearly 98% Potential Upside

Investors on the hunt for opportunities in the volatile biotechnology sector should take a closer look at Taysha Gene Therapies, Inc. (NASDAQ: TSHA). With a market..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Challenges with Strategic Workforce Solutions

AMN Healthcare Services Inc (NYSE: AMN) stands at the crossroads of healthcare and workforce management, offering a diverse array of staffing and technology-enabled solutions across the..

RxSight, Inc. (RXST) Stock Analysis: Navigating Challenges and Potential Upside in the Medical Device Sector

RxSight, Inc. (NASDAQ: RXST), a pioneering company in the medical device sector, stands at the forefront of cataract surgery innovation with its light adjustable intraocular lenses..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Eye-Catching 116% Potential Upside for Healthcare Investors

Niagen Bioscience, Inc. (NASDAQ: NAGE) is capturing the attention of investors in the healthcare sector, particularly those focused on biotechnology. With a current market capitalization of..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a Potential 61% Upside in the Biotech Sector

Pharvaris N.V. (PHVS), a Switzerland-based biopharmaceutical company, has piqued investor interest with its promising pipeline in the healthcare sector, specifically focusing on biotechnology. With a market..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Unpacking the 167% Potential Upside in Biotech

For investors seeking opportunities in the burgeoning field of biotechnology, Nurix Therapeutics, Inc. (NRIX) stands out with a compelling potential upside of 167.71%. As a clinical-stage..

Simulations Plus, Inc. (SLP) Stock Analysis: Navigating a 33% Potential Upside in Health Information Services

Simulations Plus, Inc. (NASDAQ: SLP), a prominent player in the healthcare sector, specifically within health information services, presents a compelling case for investors seeking to capitalize..

Delcath Systems, Inc. (DCTH) Investor Outlook: Exploring a 126% Potential Upside in the Medical Device Space

Delcath Systems, Inc. (NASDAQ: DCTH) is drawing increasing attention in the medical device sector with a staggering potential upside of 126.40%. Specializing in interventional oncology, Delcath..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds